To assess whether CD93 deficiency also affects vascular integrity in other metastatic tumors, we implanted Lewis lung carcinoma cells (LLC1) subcutaneously in wild-type and CD93-deficient mice. This evidence concerns the gene CD93 and metastatic neoplasm.